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Letters to the Editor 23328.0% vs. 14.9  23.6%, p  0.01) compared with the
nonfractured stent group. The absence of stent strut was the
common morphological feature of stent fracture in OCT. Both
mean and maximal neointimal area were larger in the stent
fracture group (fracture 1.59  0.75 mm2 vs. nonfracture 0.55 
.46 mm2, p  0.01; and fracture 3.30  1.73 mm2 vs.
nonfracture 1.28  1.10 mm2, p  0.01, respectively). Although
neointima grew equally in the nonfractured stent group, the
distribution of neointimal area showed a peak at the fracture site
in the fractured stent group (Fig. 2). The longitudinal length of
the absence of stent struts was positively correlated with the
neointimal area at the fracture site (r  0.79, p  0.01). From
the receiver-operating characteristics curve, the best cutoff value
of the length of the absence of stent struts to diagnose stent
fracture was 1.07 mm (area under the curve 0.85, sensitivity 93%,
and specificity 80%).
The absence of stent strut was the common morphological
feature of stent fracture, and its length was correlated with the
neointimal area. These results suggest that the loss of stent strut
itself is one of the important contributors to excessive neointimal
growth. Previous ex vivo studies reported that cyclic stretch on
cultured cells induces the proliferation of vascular smooth
muscle cells. We have reported that stent fracture frequently
occurs at bend lesions (4). When stent fracture occurs, the stent
loses its ability to scaffold the artery wall against mechanical
stress. We speculate that occurrence of these mechanical stresses
at the fracture site could contribute to excessive neointimal
growth. Furthermore, many previous studies have postulated
other causes for SES restenosis including stent under-expansion,
polymer disruption, stent strut inconsistent distribution, and
stent fracture. These factors could directly or indirectly affect the
drug delivery. Even though it is difficult to know when the stent
was fractured, we speculate that a loss of stent struts at the
fracture site may impede effective local drug delivery, resulting in
Figure 2. Neointimal Hyperplasia Area and Distance From the
Fracture Site
The distribution of neointimal hyperplasia shows a peak at the fracture site.
Data are shown as mean with SD.failure to prevent the neointimal growth. cThis study has several limitations. We only analyzed a small
number of fractured stents. Fluoroscopy might miss small stent
fractures because of its low spatial resolution. Thrombus or lipid
components may disturb the accurate assessment of neointima
area. There is also a possibility that stent struts covered with
thick neointima may be misdiagnosed as the disappearance of
stent struts. In conclusion, OCT could diagnose stent fracture,
and neointimal hyperplasia is enhanced at the fracture site.
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T2-Weighted CMR
But Where Is Elvis in the End?
A few months ago, in an editorial by Raman et al. (1), T2-weighted
(T2w) short tau inversion recovery (STIR) imaging, the only
alidated T2 sequence that was tested against pathology in an
experimental setting to assess the myocardial area at risk (AAR),
was almost thrown out the window because of its limited accuracy
and poor reproducibility due to the high sensitivity to artifacts.
However, there was still hope, because better sequences have come
out (T2w ACUTE [Acquisition for Cardiac Unified T2 Edema],
T2prep steady-state free precession, T2 mapping) with significantly
etter reproducibility and accuracy. But those sequences have not
een validated against pathology.
In a recent issue of iJACC, Fuernau and Eitel et al. (2) have
ublished successively several papers about large groups of acute
T-segment elevation myocardial infarction patients in whom
2wSTIR was used to assess the AAR. Their results showed that
2wSTIR had a significant prognostic value, and it was well
orrelated to angiographic surrogates of the myocardial AAR. At
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Letters to the Editor234the same time, we have shown (3) in an experimental model of
ischemia reperfusion that T2wSTIR and T2wACUTE were sig-
nificantly correlated to the AAR by pathology, but significantly
overestimated it.
All of these recent publications leave the reader uncertain and
confused about the utility and reliability of T2w imaging.
In that same issue of iJACC, Friedrich et al. (4) boldly decided to
pen the debate between the AAR T2w imaging pro and cons. As
always, in such a debate, the truth probably lies somewhere in
between.
What are the facts most of us agree on?
• T2w imaging shows myocardial edema as a marker of acute
injury.
T2w imaging is convenient and simple, can be applied retrospec-
tively after reperfusion, and provides incremental data to delayed
enhancement imaging.
T2w imaging and especially the classic T2wSTIR sequence is
sensitive to many artifacts that can alter the data interpretation
and analysis.
• Myocardial edema detected by T2w cardiac magnetic resonance
is correlated to the myocardial AAR, although correlation does
not mean causation.
There currently are no guidelines for post-processing of T2
hyperenhancement and association to delayed-enhancement measure-
ment thresholds.
What are the main points of disagreement?
T2w imaging provides an accurate measurement of the AAR. If
the definition of the AAR is purely perfusional (the area of
jeopardized myocardium during the coronary occlusion), then
using T2w edema to assess the AAR assumes there is a perfect
and direct relationship between the area of edema and the area of
jeopardized myocardium. When we put this in a pathophysio-
logical perspective, we know that edema is also influenced by
many other factors such as microvascular obstruction, inflamma-
tion, reperfusion status, myocardial hemorrhage, reperfusion
injury, and other unknown confounders. Therefore, the assump-
tion of a direct linear relationship between the T2w hyperen-
hanced area and the AAR is potentially submitted to many
biases. This assumption ignores that retrospective T2w imaging
after reperfusion provides a global assessment of ischemic as well
as reperfusion damage, 2 complex but cumulative and nonlinear
phenomena. To accept T2w imaging as a method of reference for
the assessment of the AAR, you would have either to neglect the
effect of factors other than ischemia, such as reperfusion injury,
or create a new definition for the AAR.
The place of interstitial edema in the explanation of T2w
enhancement is unclear. Friedrich et al. (4) provide a very elegant
explanation of intracellular edema at the acute phase of infarc-
tion but do not mention interstitial edema. Edema in the
interstitium follows a passive diffusion and would go out of the
initial AAR vascular bed bounds as we showed recently (3). If
the interstitial space is negligible in comparison to myocardial
cells in the healthy myocardium, it increases significantly in the
ischemic myocardium and is a probable major player in the
well-described overestimation of infarct size by contrast-enhanced cardiac magnetic resonance at the acute phase of
myocardial infarction. This is so true that early gadolinium
enhancement has recently been compared in iJACC to T2w
imaging with acceptable levels of correlation and proposed as a
new method to measure the AAR (5).
Like many others, we believe that T2w imaging has a lot to offer
or the assessment of acute myocardial infarction patients, but we
ave to stay close to pathophysiology and not only look at pretty
ictures if we want to get closer to truth.
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REPLY
We thank Dr. Mewton and colleagues for their interest in our paper
(1) and applaud them for raising an important point concerning the
validity of current T2-weighted CMR imaging to visualize the area
at risk in reperfused myocardial infarction (MI).
While technical issues with CMR imaging will be resolved by
improved T2-weighted imaging protocols or novel T2 mapping
techniques, the relationship of myocardial edema to the underlying
pathophysiology deserves attention.
Recent animal data have confirmed an excellent agreement of
findings in T2-weighted images with pathology in early reperfused
MI (2). The amount of peri-infarct edema in clinical studies,
however, varies significantly (3) and thus needs to be further
studied. Specifically, there is a lack of validation data on the impact
of potential confounders related to reperfusion. It is very likely that
reperfusion injury with associated peri-infarct inflammation and
microvascular dysfunction will modify the extent of myocardial
edema. A recent study by Mewton et al. (4) indicates that
reperfusion after a 40-min period of coronary occlusion may
increase the extent of edema and thus apparent “myocardial
salvage” within the first 90 min. Regarding late reperfusion,
previous clinical studies showing edema adjacent to the necrotic
